Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/21/26 18:56 | 1/21/26 | CABA | Health | BioPrd | Biological Products, (No Diag | Chang David J. | PA | O | Chief Me | P | 20 | 2.26 | 0 | 9 | New | 9 | D | ||||||||||||||
1/21/26 18:56 | 1/21/26 | CABA | Health | BioPrd | Biological Products, (No Diag | Binder Gwendolyn | PA | O | P,Scienc | P | 25 | 2.19 | 0 | 11 | 57 | 31 | D | ||||||||||||||
1/21/26 18:55 | 1/21/26 | CABA | Health | BioPrd | Biological Products, (No Diag | Tomasello Shawn | PA | D | P | 50 | 2.21 | 0 | 23 | New | 23 | I | |||||||||||||||
1/21/26 18:55 | 1/21/26 | CABA | Health | BioPrd | Biological Products, (No Diag | Gavel Steve | PA | O | CHIEF CO | P | 50 | 2.27 | 0 | 22 | New | 22 | D | ||||||||||||||
1/21/26 18:54 | 1/21/26 | CABA | Health | BioPrd | Biological Products, (No Diag | Bollard Catherine | PA | D | P | 10 | 2.27 | 0 | 4 | 441 | 5 | D | |||||||||||||||
1/21/26 18:54 | 1/21/26 | CABA | Health | BioPrd | Biological Products, (No Diag | Nichtberger Steven | PA | DO | P,CEO | P | 101 | 2.24 | 0 | 45 | 3 | 1,394 | D | ||||||||||||||
1/21/26 18:53 | 1/21/26 | CABA | Health | BioPrd | Biological Products, (No Diag | Simon Mark | PA | D | P | 25 | 2.28 | 0 | 11 | 8 | 154 | D | |||||||||||||||
1/21/26 18:53 | 1/21/26 | CABA | Health | BioPrd | Biological Products, (No Diag | Gerard Michael | PA | O | GC | P | 15 | 2.27 | 0 | 7 | New | 7 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |